Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-880P is a pseudogene related to the U6 small nuclear RNA family, which are normally critical for spliceosome function and pre-mRNA splicing in eukaryotic cells[1][3][6]. However, as a pseudogene, RNU6-880P does not produce functional RNA or snRNP complexes and is presumed to be non-expressed and non-functional within the genome[5]. The U6 snRNA family itself is one of the most highly conserved components of the spliceosome, but only a subset of annotated U6 loci in the human genome are transcribed and active; most are unexpressed pseudogenes like RNU6-880P[4][6]. These pseudogenes are considered genomic "backups" or remnants and do not play a known role in cell biology or pathophysiology[5][6]. Key distinctions: - RNU6-880P is not a receptor, enzyme, transporter, or any kind of therapeutic target. - This gene should be classified as a non-target, and its annotation is correct as a pseudogene, not a misnomer[5].
None. There are no mechanisms of action associated with this pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 880, pseudogene (RNU6-880P).